Lebwohl David
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Lebwohl David. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| NTLA | EVP, Chief Medical Officer | Award / Grant | 43,200 | — | — | Mar 1, 2025 |
| NTLA | EVP, Chief Medical Officer | Sale | 9,557 | $12.18 | $116,404 | Jan 3, 2025 |
| NTLA | EVP, Chief Medical Officer | Option Exercise | 3,189 | — | — | Jan 1, 2025 |
| NTLA | EVP, Chief Medical Officer | Award / Grant | 38,701 | — | — | Mar 1, 2024 |
| NTLA | EVP, Chief Medical Officer | Sale | 5,843 | $29.46 | $172,135 | Jan 3, 2024 |
| NTLA | EVP, Chief Medical Officer | Option Exercise | 3,187 | — | — | Jan 1, 2024 |
| NTLA | EVP, Chief Medical Officer | Award / Grant | 30,674 | — | — | Mar 1, 2023 |
| NTLA | EVP, Chief Medical Officer | Sale | 2,574 | $37.21 | $95,779 | Jan 4, 2023 |
| NTLA | EVP, Chief Medical Officer | Option Exercise | 3,187 | — | — | Jan 1, 2023 |
| NTLA | EVP, Chief Medical Officer | Option Exercise | 3,187 | — | — | Mar 1, 2022 |
| NTLA | EVP, Chief Medical Officer | Sale | 1,200 | $131.71 | $158,052 | Nov 5, 2021 |
| NTLA | EVP, Chief Medical Officer | Option Exercise | 2,400 | $12.62 | $30,288 | Oct 14, 2021 |
| NTLA | EVP, Chief Medical Officer | Option Exercise | 7,923 | $12.62 | $99,988 | Sep 24, 2021 |
| NTLA | EVP, Chief Medical Officer | Option Exercise | 2,400 | $12.62 | $30,288 | Sep 21, 2021 |
| NTLA | EVP, Chief Medical Officer | Sale | 700 | $156.70 | $109,690 | Aug 30, 2021 |
| NTLA | EVP, Chief Medical Officer | Sale | 2,400 | $164.05 | $393,720 | Aug 9, 2021 |